GSO ISO/TR 37137:2024

Gulf Standard   Current Edition
· Approved on 25 April 2024 ·

Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants

GSO ISO/TR 37137:2024 Files

English 17 Pages
Current Edition Reference Language

GSO ISO/TR 37137:2024 Scope

The objective of ISO/TR 37137:2014 is to provide interim Part-by-Part guidance on potential adjustments to various test methods within the 10993 series to account for the intentional release of soluble components or degradation products from absorbable medical devices. The content is intended to add clarity and present potentially acceptable approaches for reducing the possibility of erroneous or misleading results due to the nature of the absorbable material. All suggestions should be considered as preliminary and subject to change, with final dispositions implemented through direct modification to the respective parts of ISO 10993. Thus, interim adoption of any of the described adjustments requires an accompanying written justification.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)

Recently Published from Health Sector

GSO ISO 17069:2024
ISO 17069:2020 
Gulf Standard
Accessible design — Consideration and assistive products for accessible meeting
GSO ISO 11608-6:2024
ISO 11608-6:2022 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 6: On-body delivery systems
GSO ISO 16256:2024
ISO 16256:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases
GSO ISO 14708-3:2024
ISO 14708-3:2017 
Gulf Standard
Implants for surgery — Active implantable medical devices — Part 3: Implantable neurostimulators